Technology

September 11, 2009 – Terumo Interventional Systems yesterday announced the expansion of its Pinnacle Destination Guiding Sheaths with an 8 French size to extend the range of interventional procedures that can be performed, including atherectomy and stent graft procedures.

Home September 11, 2009
Home
Feature | Dave Fornell

Gregg W. Stone, M.D., offered a preview Sept. 10 of some of the key, late-breaking clinical trials and trends in interventional cardiology that will be presented during the Transcatheter Therapeutics (TCT) 2009 Symposium Sept. 21-25 in San Francisco.

Home September 10, 2009
Home
News

September 10, 2009 – Regado Biosciences said this week it enrolled the first patient in a phase 2b, randomized, partially-blinded, multicenter, active-controlled, dose-ranging study of its REG1 anticoagulation system.

Home September 10, 2009
Home
Feature | Cristen C. Bolan

September 10, 1009 - With the details over medical imaging equipment utilization rates and Medicare reimbursement cuts for diagnostic imaging still on the table, President Obama’s televised speech on healthcare reform last night drew reaction from advocate groups like the Medical Imaging and Technology Alliance (MITA).

Home September 10, 2009
Home
Technology

September 10, 2009 – NI Medical Ltd. said yesterday it received FDA approval for its NICaS CS, a new device for the assessment of left ventricular systolic dysfunction (LVSD), to detect heart failure in its preclinical, asymptomatic phase.

Home September 10, 2009
Home
News

September 9, 2009 – As September is national peripheral arterial disease (or PAD) awareness month, the Society of Interventional Radiology is highlighting recent medical research addressing the seriousness of PAD available in the libraries for interventional radiologists and primary care physicians.

Home September 09, 2009
Home
Technology

The Arrow AutoCAT 2 WAVE Interaotic balloon pump (IABP) System provides counterpulsation support to the most unstable of IABP patients, those with tachyarrhythmias and variable pulse pressures, all while maintaining 1:1 assist and with full volume delivery to the catheter.

Home September 09, 2009
Home
Technology

September 9, 2009 – Royal Philips Electronics unveiled its PageWriter TC50 cardiograph, which uses gender-differentiated criteria to assist in the diagnosis of heart disease in women, where symptoms may be different from men. The PageWriter TC50 was launched at the European Society of Cardiology (ESC) Congress 2009 Aug. 28.

Home September 09, 2009
Home
Feature

September 9, 2009 - TeraMedica Healthcare Technology, a Milwaukee-based medical informatics company, announced the USPTO granted it the U.S. patent number 7,583,861 for its Evercore Smartstore solution, a clinical data management technology.

Home September 09, 2009
Home
News

September 9, 2009 – ProSolv CardioVascular enhanced its outcome reporting capabilities by partnering with Cedaron Medical Inc., a developer of quality measurement solutions, to provide the complete registry support that facilities need for ACC, national, and state clinical performance reporting.

Home September 09, 2009
Home
News

September 9, 2009 – Abiomed Inc. said today its percutaneous Impella ventricular assist device will be highlighted in several clinical sessions at the upcoming TCT 2009 scientific meeting Sept. 21-25, in San Francisco.

Home September 09, 2009
Home
News

September 9, 2009 – CardiacAssist Inc. said yesterday it will exhibit its TandemHeart System in San Francisco at the TCT 2009 and will highlight speakers who have used the device in their cath labs.

Home September 09, 2009
Home
News

September 8, 2009 – Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, said last week it received $36 million in financing to fund the European commercialization and U.S. premarket approval (PMA) clinical study of the company’s TactiCath force-sensing ablation catheter.

Home September 08, 2009
Home
Technology

September 8, 2009 – Actelion Pharmaceuticals U.S. Inc. recently announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis, for the treatment of New York Heart Association Class III and IV pulmonary arterial hypertension (PAH).

Home September 08, 2009
Home
News

September 8, 2009 – Siemens Healthcare and SurgiVision Inc. today announced an agreement for the codevelopment and commercialization of a real-time magnetic resonance image (MRI)-guided cardiac electrophysiology (EP) system.

Home September 08, 2009
Home
Subscribe Now